Misty Shuo Zhang
Karolinska Institutet(SE)University of Hong Kong(HK)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Ferroptosis and cancer prognosis, interferon and immune responses, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC(2019)435 cited
- → Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer(2023)103 cited
- → Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer(2022)102 cited
- → Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer(2018)57 cited
- → Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses(2022)56 cited
- → CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma(2022)54 cited
- → Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development(2023)52 cited
- → Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer(2021)52 cited
- → Polo‐like kinase 4 inhibitor CFI‐400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity(2022)36 cited
- → Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment(2022)33 cited